Bank of Montreal’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
TRCT
GS
TSS
MIG
CBU
AF
EFG
Bank of Montreal's LABU Position: Q2 2026 in Review
Bank of Montreal opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026: 200 shares worth $58.4K. The stake represents ﹤0.01% of the portfolio and ranks #3389 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in LABU as recently as Q3 2024.
Bank of Montreal first reported a position in LABU in Q4 2017 and has held it in 8 quarters since. The position peaked at $172K in Q1 2018. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.
- Bank of Montreal held 200 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $58.4K as of Q2 2026.
- Direxion Daily S&P Biotech Bull 3X ETF was a new Bank of Montreal position in Q2 2026.
- Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3389 holding.
- Bank of Montreal first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2017 and has held it in 8 quarters since.
- Bank of Montreal's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $172K in Q1 2018.
- 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.